MedTrace Logo

Application and Generalization of Flutter Mucus Clearance Device

NCT00816881 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 356

Last updated 2012-06-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus clearance devices.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DEVICE

flutter mucus clearance device

five minutes every session, four sessions per day

Sponsors & Collaborators

  • Tongji University

    lead OTHER

Principal Investigators

  • Zhang Xiangyu, MD · Shanghai 10th People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-02-28
Completion
2010-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00816881 on ClinicalTrials.gov